CHRISTOPHER CAMPBELL: Open Payments
NPI 1033515358 · COLUMBUS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 36 payments from 10 companies in 2025. Trend: 2023 $739 · 2024 $1,427 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $502 |
| Forte Bio-Pharma LLC | 8 | $138 |
| Collegium Pharmaceutical, Inc. | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Atland Pharmaceuticals, LLC | 1 | $43 |
| SCILEX PHARMACEUTICALS INC. | 2 | $40 |
| Janssen Biotech, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $19 |
| Valinor Pharma, LLC | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: PROCLAIM, OCTRODE, ETERNA, PROLATE, Belbuca, RELISTOR, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, RYBREVANT.
Industry payments across NC — which companies pay providers there.
